Search the Newsreel

Sally Beauty (SBH) Q3 2026 Earnings Call Transcript

Eli Lilly (LLY) Stock Gets Fair Value Bump After GLP 1 Driven Analyst Revisions

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Eli Lilly's updated fair value price target has shifted from US$1,270.37 to US$1,297.31, giving investors a fresh reference point for how analysts are framing the …

Eli Lilly vs. Novo Nordisk: Which Company Is Better Positioned for America’s New Drug Manufacturing Policies?

For years, investors have viewed Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) through one lens: the race to dominate the booming obesity-drug market. But Washington is beginning to shift the conversation. With the U.S. government pushing pharmaceutical companies to manufacture more medicines domestically and …

Why Eli Lilly Topped the Market Today

Key Points This market has a population of almost 60 million. While the drug isn't the first of its type to be sold in that country, it will have Lilly's considerable marketing power behind it.10 stocks we like better than Eli Lilly › Eli …

Bally’s To Pause Building Parts Of Chicago Casino Project Amid Fight Over Video Gambling Expansion

Bally's is pausing construction on certain parts of its $1.8 billion Chicago casino project, including hotel, restaurant, and event spaces, due to a dispute over the city's approval of video gambling terminals. The company argues that the expansion of video gambling breaches its host …

Bally's pauses Chicago project amid dispute with city over video gaming terminals

Bally's has paused its $1.7 billion casino project in Chicago due to a dispute with the city over the expansion of video gaming terminals (VGTs). The company claims that the potential proliferation of VGTs breaches the Host Community Agreement and creates uncertainty for its …

ALLY5473461 Bond Risk Profile

This page provides a risk profile for the ALLY5473461 bond, issued by Ally Financial Inc. It details the bond's coupon rate, redemption date, and offers tools for credit risk assessment, including issuer ratings and inflation protection. The platform also provides access to exclusive analyst …

Eli Lilly vs. Novo Nordisk: Has GLP-1 Manufacturing Become the New Competitive Moat?

The obesity-drug market has largely been viewed as a race between clinical innovation and commercial execution. Investors have spent the past three years comparing prescription growth, market share, and pipeline candidates as Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) compete for dominance in one …

O'Reilly Automotive Inc. stock outperforms competitors despite losses on the day

O'Reilly Automotive Inc. (ORLY) saw its stock slip by 1.39% to $92.23 on Monday, despite the broader market, including the S&P 500 Index and Dow Jones Industrial Average, also experiencing losses. The company's stock closed 15.16% below its 52-week high of $108.72, which was …

Eli Lilly Stock Rises 2.1% as UK Clears Obesity Pill

This article first appeared on GuruFocus. Eli Lilly (NYSE:LLY) just added another weapon to its obesity arsenal. The pharmaceutical giant received British authorization for Foundayo on Monday, making the U.K. the first European country to clear the once-daily orforglipron tablet for weight management and …

Eli Lilly and Co Stock (LLY) Moved Up by 3.48% on Aug 10: Drivers Behind the Movement

Eli Lilly and Co (LLY) saw its stock price rise by 3.48% due to an optimistic revision of its full-year guidance and successful resolution of manufacturing bottlenecks for its metabolic treatments. Favorable updates regarding its Alzheimer's drug reimbursement and Medicare coverage, alongside increased institutional …

Ally Financial Chief Risk Officer Stephanie Richard Sells 5,000 Shares

Stephanie Richard, Chief Risk Officer of Ally Financial, sold 5,000 shares of the company's common stock for $221,150 on August 4, 2026. This transaction was conducted under a Rule 10b5-1 trading plan, and she retains 88,927 shares valued at $4 million. The Motley Fool …

Sally Beauty’s Q3 results beat estimates but miss revenue

Sally Beauty reported third-quarter earnings that surpassed Wall Street estimates, reaching $54.1 million, or 55 cents per diluted share. However, the company missed revenue expectations with net sales of $935.5 million against an estimate of $936.2 million, despite a 0.2% year-over-year growth and an …

Scully Royalty adopts new policy for transparent shareholder director nominations.

Scully Royalty Ltd. has implemented an Advance Notice Policy to create a clear and structured process for shareholder nominations of directors. This policy ensures timely and accurate disclosure of nominee information, helping shareholders assess candidates' qualifications and independence. The policy aligns with the company's …

Lifespan Vision Ventures Leads Remedium Bio's Series A Financing

Investment supports advancement of Remedium's durable protein therapeutics platform toward first-in-human clinical development. NORWALK, Conn., Aug. 10, 2026 /PRNewswire/ -- Lifespan Vision Ventures today announced that it is leading Remedium Bio, Inc.'s ("Remedium") $10 million Series A financing and has completed the round's initial …

Lilly's weight-loss pill gets UK regulator's nod

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorized Eli Lilly's Foundayo pill for weight management and type 2 diabetes, making it the first European country to do so. This once-daily GLP-1 tablet has been gaining traction in the U.S. since its …

Eli Lilly (NYSE:LLY) Pairs High Growth Momentum with a Defined Breakout Setup

Bally’s Slows Chicago Casino Development Over VGT Dispute

Bally’s Chicago has significantly slowed construction on non-casino elements of its $1.7 billion River West development due to an ongoing dispute with city officials over the expansion of video gambling terminals (VGTs). The company argues that the city's plan to allow VGTs breaches their …

Scully Royalty Board Adopts Advance Notice Policy for Director Nominations

Scully Royalty Ltd. (NYSE: SRL) has announced that its Board of Directors adopted an Advance Notice Policy for director nominations, effective immediately. This Policy aims to establish a transparent and orderly process for shareholder nominations, ensuring the Company and its shareholders receive timely and …

Scully Royalty Ltd. (NYSE: SRL) sets new advance notice rules for board nominees

Scully Royalty Ltd. (NYSE: SRL) has adopted a supplemental Advance Notice Policy, effective immediately, to govern shareholder nominations for its Board of Directors. This policy, which supplements the company’s existing Articles of Association, sets detailed requirements for nomination notices, including extensive disclosures from nominating …

5 Revealing Analyst Questions From Sally Beauty’s Q2 Earnings Call

Scully Royalty Ltd. Board of Directors Adopts Advance Notice Policy for Director Nominations

Scully Royalty Ltd. (NYSE: SRL) has announced that its Board of Directors adopted an Advance Notice Policy for director nominations, effective immediately. This Policy aims to establish a transparent and orderly process for shareholder nominations, ensuring the Company and its shareholders receive timely and …

Empowered Funds LLC Has $797,000 Position in Ally Financial Inc. $ALLY

Empowered Funds LLC significantly reduced its stake in Ally Financial Inc. ($ALLY) by 65.6% in the first quarter, holding shares worth $797,000. Despite this, analysts maintain a "Moderate Buy" rating with an average price target of $53.64, compared to the stock's current price of …

Rallybio Corp (RLYB) Earnings Forecast: Future EPS & Revenue Growth Estimates

Rallybio Corp (RLYB) has an earnings forecast score of 6.00, placing it 330 out of 387 in the Biotechnology & Medical Research industry. Analysts have set an average price target of $1.00 for RLYB, with recent EPS at -$1.03 against an expectation of -$1.46. …

Tillys Inc (TLYS) Earnings Forecast: Future EPS & Revenue Growth Estimates

Nvidia, Eli Lilly, and Disney Show It’s Time to Back the Top Dogs

Investors are still skittish enough that they only want to buy proven winners, so backing the favorite is a smart strategy right now. Continue Reading

Bally's Chicago Halts Construction as Casino Ups Ante in VGT War

Bally's Chicago has paused construction on its $1.7 billion resort casino, specifically the 34-story hotel and other non-gaming amenities, in a move to pressure the City Council over its plan to authorize slot-like video gaming terminals (VGTs) across the city. The casino developer claims …

Bally's slows work on permanent Chicago casino amid standoff with city over video gambling

Bally's is slowing down construction on its permanent Chicago casino due to a dispute with the city over the potential expansion of video gambling terminals. The company views this expansion as a breach of the Host Community Agreement, creating uncertainty for its Chicago operations. …

Report: Bally’s pauses construction at River West Casino site amid gaming dispute with City of Chicago

Bally's Chicago has reportedly paused construction on non-gaming amenities at its River West casino complex due to a dispute with the City of Chicago over video game terminals (VGTs). Bally's contends that the city's legalization of VGTs violates their 2022 host agreement, leading to …

Bally’s Halts Construction on $1.7B Chicago Casino Amid Gaming Terminal Fight

Bally's has paused construction on its $1.7 billion Chicago casino resort, specifically the 34-story hotel tower and non-gaming amenities, due to a dispute with the city over a plan to legalize slot-like video gaming terminals (VGTs). The company argues that allowing VGTs violates its …

Can Kelly Services (NASDAQ:KELYA) Turn Revenue Strength Into Better Margins?

Ally Financial | 4: Statement of changes in beneficial ownership of securities-Director Reilly David

This article announces that Ally Financial's Director Reilly David has filed a Statement of Changes in Beneficial Ownership of Securities (Form 4) with the SEC. The brief entry provides the filing date and mentions that the stock symbol for Ally Financial is ALLY, with …

O'Reilly Automotive (ORLY) Stock Faces Premium Valuation After Solid Q2

Wie Investoren auf die angehobene Prognose, Aktienrückkäufe und die Strategie der „Tuck-in“-Fusionen und -Übernahmen von O’Reilly Automotive (ORLY) reagieren

O'Reilly Says It's Sharing Tariff Refunds With Suppliers. Its Balance Sheet Tells the More Interesting Version.

O'Reilly Says It's Sharing Tariff Refunds With Suppliers. Its Balance Sheet Tells the More Interesting Version. Every earnings call produces one line that matters more than the headline numbers. On O'Reilly Automotive's July 30 call, asked directly about tariffs, President Brent Kirby said the …

How Investors Are Reacting To O'Reilly Automotive (ORLY) Raised Guidance, Buybacks And Tuck-in M&A Strategy

O'Reilly Automotive (ORLY) recently reported strong Q2 2026 results with increased sales and net income, leading to raised full-year 2026 guidance. The company also completed a share repurchase program and indicated a preference for smaller, "tuck-in" acquisitions. This strategy signals management's confidence in the …